A collaboration between a British university and Indian institutions is helping improve the survival rates associated with childhood cancer in India.
The collaboration between the University of Manchester and the Tata Medical Centre in Kolkata is helping to improve cure rates in children with Acute Lymphoblastic Leukaemia (ALL) in India by 10-15 per cent.
The knowledge transfer from Manchester is also raising standards of cancer care at Paediatric Cancer Centres in Delhi, Mumbai, Chennai and Chandigarh, the university said on International Cancer Survivors Day on Sunday.
Professor Vaskar Saha, a paediatrician from the University of Manchester, has helped cure children diagnosed with ALL by 15 per cent during the five years he has led the Indian Childhood Collaborative Leukaemia Group (ICICLE) clinical project, in partnership with Tata Medical Centre in Kolkata.
"In the UK, 450 children are diagnosed annually with ALL, of which 400 will survive. In India, 9,000 of the 15,000 children diagnosed annually will survive," said Saha,
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
